Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000546101 | SCV000624590 | pathogenic | Hereditary nonpolyposis colorectal neoplasms | 2018-09-17 | criteria provided, single submitter | clinical testing | This variant is a gross deletion of the genomic region encompassing exons 11-15 of the PMS2 gene. The 5' boundary is likely confined to intron 11. The 3' end of this event is unknown as it extends through the termination codon beyond the assayed region for this gene and may encompass additional genes. While this deletion is not anticipated to result in nonsense mediated decay, it is expected to create a truncated PMS2 protein. Similar deletions of exons 11-15 have been reported in the literature in individual affected with colorectal cancer and Lynch syndrome (PMID: 20186688, 15942039). Sub-genic deletion of exons 14-15 disrupting the C-terminal portion of the MLH1 interaction domain being required for PMS2-MLH1 dimerization (PMID: 10037723) and mismatch repair activity (PMID: 16338176, 20533529) has been determined to be pathogenic (PMID: 21618646, 24440087, 26318770, Invitae). Therefore, deletions that fully encompass that region are also expected to be pathogenic. For these reasons, this variant has been classified as Pathogenic. |